VB10.16 clinical trials

Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma

This study is for people with a certain type of advanced head and neck cancer linked to HPV. It's testing a new 'vaccine-like' treatment called VB10.16 combined with an existing medicine, pembrolizumab, to see if it's safe and effective.